Description
Doramapimodisananticancerchemotherapeuticinhibitorofp38MAPKandJNKthatalsodisplayssomeinvitroactivityagainstanaplasticlymphomakinase(ALK).Doramapimodiscurrentlyinclinicaltrialsasapotentialtreatmentforinflammatorydiseases,exhibitinganti-inflammatoryactivity.Invitro,thiscompoundinhibitsexpressionofCOX-2,MMP13,iNOS,andTNF-αanddecreasesreleaseofprostaglandinE2(PGE2),decreasingtheoverallinflammatoryresponse.
References
HoogendijkAJ,PinhançosSS,vanderPollT,etal.IntrapulmonaryadmiNISTrationofap38mitogenactivatedproteinkinaseinhibitorpartiallypreventspulmonaryinflammation.ImmunoBIOLOGy.2013Apr;218(4):435-42.PMID:22727776.
afGennäsGB,MologniL,AhmedS,etal.Design,synthesis,andbiologicalactivityofureaderivativesasanaplasticlymphomakinaseinhibitors.ChemMedChem.2011Sep5;6(9):1680-92.PMID:21721129.
KuglstatterA,GhateM,TsingS,etal.X-raycrystalstructureofJNK2complexedwiththep38alphainhibitorBIRB796:insightsintotherationaldesignofDFG-outbindingMAPkinaseinhibitors.BioorgMedChemLett.2010Sep1;20(17):5217-20.PMID:20655210.
JoosH,AlbrechtW,LauferS,etal.Differentialeffectsofp38MAPkinaseinhibitorsontheexpressionofinflammation-associatedgenesinprimary,interleukin-1beta-stimulatedhumanchondrocytes.BrJPharmacol.2010Jul;160(5):1252-62.PMID:20590617.
GruenbaumLM,SchwartzR,WoskaJRJr,etal.Inhibitionofpro-inflammatorycytokineproductionbythedualp38/JNK2inhibitorBIRB796correlateswiththeinhibitionofp38signaling.BiochemPharmacol.2009Feb1;77(3):422-32.PMID:19027720.
KumaY,SABIoG,BainJ,etal.BIRB796inhibitsallp38MAPKisoformsinvitroandinvivo.JBiolChem.2005May20;280(20):19472-9.PMID:15755732.